Log in to save to my catalogue

Reduced guanidinoacetate in plasma of patients with autosomal dominant Fanconi syndrome due to heter...

Reduced guanidinoacetate in plasma of patients with autosomal dominant Fanconi syndrome due to heter...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_ed57ef7a83974f628ba4c03ecfbbcf4e

Reduced guanidinoacetate in plasma of patients with autosomal dominant Fanconi syndrome due to heterozygous P341L GATM variant and study of organoids towards treatment

About this item

Full title

Reduced guanidinoacetate in plasma of patients with autosomal dominant Fanconi syndrome due to heterozygous P341L GATM variant and study of organoids towards treatment

Publisher

Hoboken, USA: John Wiley & Sons, Inc

Journal title

JIMD Reports, 2024-09, Vol.65 (5), p.341-353

Language

English

Formats

Publication information

Publisher

Hoboken, USA: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

Autosomal dominant Fanconi syndrome due to a GATM variant (GATM‐FS), causes accumulation of misfolded arginine‐glycine amidinotransferase (AGAT) in proximal renal tubules leading to cellular injury. GATM‐FS presents during childhood and progresses to end‐stage kidney disease (ESKD) in adults. We study creatine metabolism in two individuals of unrel...

Alternative Titles

Full title

Reduced guanidinoacetate in plasma of patients with autosomal dominant Fanconi syndrome due to heterozygous P341L GATM variant and study of organoids towards treatment

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_ed57ef7a83974f628ba4c03ecfbbcf4e

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_ed57ef7a83974f628ba4c03ecfbbcf4e

Other Identifiers

ISSN

2192-8312,2192-8304

E-ISSN

2192-8312

DOI

10.1002/jmd2.12442

How to access this item